To develop more practical and less toxic brokers to deal with infectious ailments is still a problem to the pharmaceutical chemist. A large amount of effort has long been invested before decade to develop benzofuran-dependent compounds as microbial agents which have been Energetic on various clinically approved therapeutic targets and show excellen